Krishna Institute of Medical Sciences Ltd
Ticker: KIMS
Decent
66/100
☆ Add to Watchlist
Investing Reference
Price
727.45
Market Cap
29108.11
Debt/Equity
1.0570
ROE %
17.043
PB
12.0341
Promoter %
34.110
Pledge %
0.000
1Y Rev Growth %
22.563
5Y Rev Growth %
22.217
NP Margin %
12.493
NP Margin 5Y Avg %
14.936
Trading Reference
1M Return %
-5.456
6M Return %
15.368
1Y Return %
30.029
% Away 52W High
9.753
% Away 52W Low
53.454
Daily Volume
245939
Investment Verdict
Risky
Score 57/100 · Position size: 6%
Higher volatility/weak areas. Consider only a small allocation if risk appetite is high.
Trading Verdict
Avoid
Score 45/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Based on current technical analysis, Krishna Institute of Medical Sciences Ltd is likely to face resistance around the ₹1,200 level, with support at ₹1,000. If the stock can break above the resistance with strong volume, it may see an upside of approximately 15%. Conversely, if it falls below the support level, a downside of about 10% could occur.
Upside Probability: 15% | Downside Probability: 10%
Probability estimates are technical-context statements, not investment advice.
More Options
A
Apollo Tyres Ltd
Apollo Tyres Ltd shows potential for growth but faces challenges in profitability and valuation. Investors should be cautious.
View details
I
Indraprastha Gas Ltd
Indraprastha Gas Ltd shows decent fundamentals with growth potential, but investors should be cautious of execution risks and valuation levels.
View details
I
ITI Ltd
ITI Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
G
Gujarat Gas Ltd
Gujarat Gas Ltd shows decent potential with solid growth prospects, but investors should be cautious of valuation and execution risks.
View details
G
Garden Reach Shipbuilders & Engineers Ltd
Garden Reach Shipbuilders & Engineers Ltd shows potential for growth, but faces challenges in profitability and execution risks.
View details
A
Affle 3i Ltd
Affle 3i Ltd shows potential for growth in a promising sector, but valuation concerns and execution risks warrant caution.
View details
I
ICICI Securities Ltd
ICICI Securities Ltd shows decent potential with a stable business model and growth prospects, but faces challenges in profitability and market competition.
View details
A
AIA Engineering Ltd
AIA Engineering Ltd shows potential for growth, but investors should be cautious of valuation and execution risks.
View details
N
NBCC (India) Ltd
NBCC (India) Ltd presents a risky investment due to inconsistent growth and market challenges, despite some strengths in its business model.
View details
T
Tata Technologies Ltd
Tata Technologies Ltd shows potential for growth, but investors should be cautious due to fluctuating profitability and execution risks.
View details
K
KIOCL Ltd
KIOCL Ltd shows potential for growth in a stable sector, but faces challenges in profitability and valuation metrics.
View details
D
Dr. Lal PathLabs Ltd
Dr. Lal PathLabs Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
S
Sumitomo Chemical India Ltd
Sumitomo Chemical India Ltd shows potential for growth, but faces challenges in profitability and execution risks.
View details
A
Aegis Vopak Terminals Ltd
Aegis Vopak Terminals Ltd shows potential for growth but faces challenges in profitability and valuation. Investors should be cautious.
View details
H
Hindustan Copper Ltd
Hindustan Copper Ltd shows potential but faces significant challenges in growth and profitability, making it a risky investment at this time.
View details
T
TVS Holdings Ltd
TVS Holdings Ltd shows potential for growth, particularly in the electric vehicle segment, but faces challenges in profitability and valuation metrics.
View details
Business Overview
Krishna Institute of Medical Sciences Ltd (KIMS) is a leading healthcare provider in India, dedicated to delivering high-quality medical services across various specialties. Catering to patients seeking comprehensive and compassionate care, KIMS is recognized for its advanced facilities and skilled medical professionals. The institute plays a crucial role in enhancing healthcare accessibility and outcomes in the region, making it a trusted choice for patients and families alike.
- Established leader in healthcare services
- Wide range of medical specialties
- State-of-the-art medical facilities
- Highly qualified and experienced staff
- Commitment to patient-centered care
- Focus on improving healthcare accessibility
Investment Thesis
Krishna Institute of Medical Sciences Ltd stands out with a strong promoter group and credibility in the healthcare sector. The company's digital services are poised for significant growth, enhancing operational efficiency. Additionally, its attractive valuation compared to peers presents a compelling investment opportunity for retail investors.
- Strong promoter group with a proven track record in healthcare.
- Significant growth potential in digital healthcare services.
- Attractive valuation compared to industry peers, offering upside.
- Robust operational framework enhancing service delivery.
- Positive market sentiment towards healthcare sector growth.
Opportunity vs Risk
Opportunities
- Growing healthcare demand in India
- Expansion into new regions
- Strong government healthcare initiatives
- Rising medical tourism
- Innovative healthcare technologies adoption
Risks ⚠️
- Regulatory changes affecting operations
- High competition in healthcare sector
- Economic downturn impacts spending
- Dependence on skilled workforce
- Potential for rising operational costs
Peer Perspective
Krishna Institute of Medical Sciences Ltd trades at a discount to peers like Fortis Healthcare and Apollo Hospitals, primarily due to margin pressures; a sustained improvement in operational efficiency could trigger a rerating.
Future Outlook
Krishna Institute of Medical Sciences Ltd is well-positioned for growth, driven by increasing healthcare demand. Successful execution of expansion plans and effective cost control will be crucial to maximizing shareholder value.
AI FAQs for Retail Users
- Q: What does Krishna Institute of Medical Sciences Ltd do?A: It operates hospitals and provides healthcare services across various specialties in India.
- Q: Is Krishna Institute of Medical Sciences Ltd publicly traded?A: Yes, it is listed on the National Stock Exchange of India and the Bombay Stock Exchange.
- Q: What factors can affect the stock price?A: Factors include healthcare regulations, hospital occupancy rates, and overall market conditions.
- Q: How can I invest in Krishna Institute of Medical Sciences Ltd?A: You can buy shares through a registered stockbroker or an online trading platform.
- Q: What should I consider before investing?A: Evaluate the company's financial health, market position, and your investment goals.
📊 Stock Investment Checklist (100 Points)
Krishna Institute of Medical Sciences Ltd • Updated: 2025-09-18 08:55:56
-
10BusinessHighHealthcare sector is essential and growing, but competition is intense.
-
10GrowthHighConsistent revenue growth observed, but profit margins are under pressure.
-
10ProfitabilityHighROE and ROCE are decent, but OCF is fluctuating.
-
8ValuationHighValuation metrics are above industry average, indicating potential overvaluation.
-
7BalanceHighModerate debt levels, but liquidity is adequate.
-
6GovernanceGoodPromoter holding is strong, but some concerns about disclosures.
-
5DriversGoodGrowth drivers exist, but execution risks are significant.
-
5TechnicalsGoodMarket sentiment is mixed, with low liquidity.
Final Score & Verdict
Score 66 / 100
• Decent
The stock shows decent potential in a growing sector, but faces challenges in profitability and valuation metrics.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 72/100